光線性角化症治療市場レポート：タイプ別、薬剤タイプ別、流通チャネル別、地域別、2024～2032年

世界の光線性角化症治療市場規模は2023年に64億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに97億米ドルに達し、2024～2032年の間に4.5％の成長率（CAGR）を示すと予測しています。

太陽角化症としても知られる光線性角化症は、日光にさらされた部分に発症する皮膚疾患を指します。手、腕、唇、頭皮、その他の体の部位にざらざらしたうろこ状の斑点が現れ、扁平上皮がんと呼ばれる皮膚がんに発展する可能性があります。光線力学的療法には、凍結療法、掻爬療法、レーザー療法などがあります。現在、医療インフラの大幅な拡大と、がんの予防戦略に対するニーズの高まりが、世界の光線性角化症治療需要にプラスの影響を与えています。

光線性角化症治療市場動向

オゾン層の破壊と過度の日光暴露による光線性角化症の有病率の増加は、市場の成長を促進する主要要因の一つです。さらに、がんの罹患率の上昇と低侵襲（MI）処置の需要の高まりが相まって、市場の成長を強化しています。さらに、大手メーカーは、クリームやジェル状の光線性角化症治療を発売しており、これが市場成長を後押ししています。これとは別に、数多くの公的・民間団体が、世界中で利用可能な光線性角化症の治療法に関する認知度を高めるためのキャンペーン実施に注力しています。これに加えて、有効性の向上、簡便な投与、コスト削減を実現した新規治療法を開発するための研究開発（R&D）活動への多額の投資が、市場の展望を良好なものにしています。また、瘢痕化のリスクを軽減する局所治療の採用も市場を牽引しています。この治療はまた、皮膚上の目に見える、あるいは目に見えない病変を広範囲に治療するためにも使用されます。これに加えて、有利な償還政策が市場の成長を促進すると予想されます。

本レポートで扱う主要質問

• 世界の光線性角化症治療市場はこれまでどのように推移してきたか？
• COVID-19が世界の光線性角化症治療市場に与えた影響は？
• 主要地域市場とは？
• タイプ別の市場内訳は？
• 薬剤タイプ別の市場内訳は？
• 流通チャネル別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主要促進要因と課題は何か？
• 世界の光線性角化症治療市場の構造と主要参入企業は？
• 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の光線性角化症治療市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 処方箋
• 店頭

第7章 市場内訳：薬剤タイプ別

• フルオロウラシル
• イミキモド
• ジクロフェナク
• その他

第8章 市場内訳：流通チャネル別

• 病院薬局
• ドラッグストアと薬局
• オンラインストア

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • 3M Company
  • Almirall SA
  • Bausch Health Companies Inc.
  • Biofrontera Inc.
  • BioLineRx Ltd.
  • Cipher Pharmaceuticals Inc
  • Galderma SA
  • Hill Dermaceuticals Inc.
  • LEO Pharma A/S
  • Sun Pharmaceutical Industries Ltd.

List of Figures

• Figure 1: Global: Actinic Keratosis Treatment Market: Major Drivers and Challenges
• Figure 2: Global: Actinic Keratosis Treatment Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Actinic Keratosis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Actinic Keratosis Treatment Market: Breakup by Type (in %), 2023
• Figure 5: Global: Actinic Keratosis Treatment Market: Breakup by Drug Type (in %), 2023
• Figure 6: Global: Actinic Keratosis Treatment Market: Breakup by Distribution Channel (in %), 2023
• Figure 7: Global: Actinic Keratosis Treatment Market: Breakup by Region (in %), 2023
• Figure 8: Global: Actinic Keratosis Treatment (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Actinic Keratosis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Actinic Keratosis Treatment (OTC) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Actinic Keratosis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Actinic Keratosis Treatment (Fluorouracil) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Actinic Keratosis Treatment (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Actinic Keratosis Treatment (Imiquimod) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Actinic Keratosis Treatment (Imiquimod) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Actinic Keratosis Treatment (Diclofenac) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Actinic Keratosis Treatment (Diclofenac) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Actinic Keratosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Actinic Keratosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Actinic Keratosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Actinic Keratosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: North America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: North America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: United States: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: United States: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Canada: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Canada: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Asia-Pacific: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Asia-Pacific: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: China: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: China: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Japan: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Japan: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: India: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: India: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: South Korea: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: South Korea: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Australia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Australia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Indonesia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Indonesia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Europe: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Europe: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Germany: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Germany: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: France: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: France: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: United Kingdom: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: United Kingdom: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Italy: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Italy: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Spain: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Spain: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Russia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Russia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Latin America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Latin America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Brazil: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Brazil: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Mexico: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Mexico: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Middle East and Africa: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Middle East and Africa: Actinic Keratosis Treatment Market: Breakup by Country (in %), 2023
• Figure 74: Middle East and Africa: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Global: Actinic Keratosis Treatment Industry: SWOT Analysis
• Figure 76: Global: Actinic Keratosis Treatment Industry: Value Chain Analysis
• Figure 77: Global: Actinic Keratosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Actinic Keratosis Treatment Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 3: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
• Table 4: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
• Table 5: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Actinic Keratosis Treatment Market: Competitive Structure
• Table 7: Global: Actinic Keratosis Treatment Market: Key Players

The global actinic keratosis treatment market size reached US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

Actinic keratosis, also known as solar keratosis, refers to a skin condition that develops on the sun-exposed areas of the body. It causes rough, scaly patches to appear on the hands, arms, lips, scalp, and other body parts that can further develop into a skin cancer called squamous cell carcinoma. Some of the commonly used treatments to remove actinic keratosis include cryotherapy, curettage, laser therapy, and photodynamic therapy. At present, the considerably expanding healthcare infrastructure and increasing need for preventive strategies for cancer are positively influencing the demand for actinic keratosis treatment worldwide.

Actinic Keratosis Treatment Market Trends:

The increasing prevalence of actinic keratosis due to ozone layer depletion and excessive sun exposure represents one of the key factors fueling the growth of the market. Additionally, the rising incidences of cancer, coupled with the escalating demand for minimally invasive (MI) procedures, is strengthening the market growth. Furthermore, leading manufacturers are introducing medications for the treatment of actinic keratosis in the form of cream and gel, which is impelling the market growth. Apart from this, numerous public and private groups are focusing on conducting campaigns to generate awareness about available treatments for actinic keratosis across the globe. This, along with significant investments in the research and development (R&D) activities to develop novel therapies with improved efficacy, convenient dosage, and reduced costs, is creating a favorable market outlook. The market is also driven by the introduction of topical treatment that reduces the risk of scarring. This treatment is also used for treating a wide area of visible and invisible lesions on the skin. Besides this, favorable reimbursement policies are anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global actinic keratosis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, and distribution channel.

Breakup by Type:

Prescription

OTC

Breakup by Drug Type:

Fluorouracil

Imiquimod

Diclofenac

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Drug Stores and Retail Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

• How has the global actinic keratosis treatment market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global actinic keratosis treatment market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the drug type?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global actinic keratosis treatment market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Actinic Keratosis Treatment Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Prescription
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 OTC
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

• 7.1 Fluorouracil
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Imiquimod
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Diclofenac
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Drug Stores and Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Stores
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Almirall SA
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Bausch Health Companies Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Biofrontera Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 BioLineRx Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 Cipher Pharmaceuticals Inc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Galderma SA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 SWOT Analysis
  • 14.3.8 Hill Dermaceuticals Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 LEO Pharma A/S
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Sun Pharmaceutical Industries Ltd.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis